Beyond tumor mutation burden: tumor neoantigen burden as a superior prognostic biomarker in resected gastric cancer. [PDF]
Lu T +13 more
europepmc +1 more source
YIPFα1A expression is regulated by multilayered molecular mechanisms
YIPFα1A, a five‐pass Golgi protein, is regulated at multiple layers. (1) Rare‐codon enrichment drives translation‐coupled mRNA decay. (2) A proximal 3′‐UTR element stabilizes mRNA. (3) A distal 3′‐UTR element included by alternate poly(A) site usage represses translation, which can be overridden by the proximal 3′‐UTR element.
Tokio Takaji +2 more
wiley +1 more source
Nivolumab–ipilimumab — exploiting the mutation burden of NSCLCs [PDF]
openaire +2 more sources
Supplementary Figure S1 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma [PDF]
Aude Fléchon +30 more
openalex +1 more source
iRUNNER: A Baseline Mutation Burden Regression for Identifying Gene Interaction Between Rare Variants for Diseases. [PDF]
Jiang 江慧 H +13 more
europepmc +1 more source
The MRP4 transporter exports several drugs and signaling molecules. Here, we identified key promoter elements regulating basal MRP4 expression. Using reporter assays, we defined a conserved region with essential Sp1 and contributory Ets sites, which controlled basal MRP4 expression.
Debora Singer +7 more
wiley +1 more source
Sex differences in gastric cancer mutational burden reflect MLH1-associated epigenetic regulation
Noa Klein, Dorit Shweiki
openalex +1 more source
Systematic literature review on the prevalence and burden of estrogen receptor 1 (ESR1) gene mutations in advanced breast cancer [PDF]
Kimberly Ruiz +2 more
openalex +1 more source
Impact of tumor mutation burden on the prognosis of patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolization combined with immunotherapy and anti-angiogenic drugs. [PDF]
Huang XW, Wang DJ, Cai BZ.
europepmc +1 more source

